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Nemaline myopathy is a congenital neuromuscular disorder characterized by muscle
weakness, fiber atrophy and presence of nemaline bodies within myofibers. However, the
understanding of underlying pathomechanisms is lacking. Recently, mutations in
KBTBD13, KLHL40 and KLHL41, three substrate adaptors for the E3-ubiquitin ligase
Cullin-3, have been associated with early-onset nemaline myopathies. We hypothesized
that deregulation of Cullin-3 and its muscle protein substrates may be responsible for the
disease development. Using Cullin-3 knockout mice, we identified accumulation of nonmuscle alpha-Actinins (ACTN1 and ACTN4) in muscles of these mice, which we also
observed in KBTBD13 patients. Our data reveal that proper regulation of Cullin-3 activity
and ACTN1 levels is essential for normal muscle and neuromuscular junction development.
While ACTN1 is naturally downregulated during myogenesis, its overexpression in C2C12
myoblasts triggered defects in fusion, myogenesis and acetylcholine receptor clustering;
features that we characterized in Cullin-3 deficient mice. Taken together, our data highlight
the importance for Cullin-3 mediated degradation of ACTN1 for muscle development, and
indicate a new pathomechanism for the etiology of myopathies seen in Cullin-3 knockout
mice and nemaline myopathy patients.
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ABSTRACT
Nemaline myopathy is a congenital neuromuscular disorder characterized by muscle
weakness, fiber atrophy and presence of nemaline bodies within myofibers. However,
the understanding of underlying pathomechanisms is lacking. Recently, mutations in
KBTBD13, KLHL40 and KLHL41, three substrate adaptors for the E3-ubiquitin ligase
Cullin-3, have been associated with early-onset nemaline myopathies. We hypothesized
that deregulation of Cullin-3 and its muscle protein substrates may be responsible for
the disease development.
Using Cullin-3 knockout mice, we identified accumulation of non-muscle alpha-Actinins
(ACTN1 and ACTN4) in muscles of these mice, which we also observed in KBTBD13
patients. Our data reveal that proper regulation of Cullin-3 activity and ACTN1 levels is
essential for normal muscle and neuromuscular junction development. While ACTN1 is
naturally downregulated during myogenesis, its overexpression in C2C12 myoblasts
triggered defects in fusion, myogenesis and acetylcholine receptor clustering; features
that we characterized in Cullin-3 deficient mice.
Taken together, our data highlight the importance for Cullin-3 mediated degradation of
ACTN1 for muscle development, and indicate a new pathomechanism for the etiology of
myopathies seen in Cullin-3 knockout mice and nemaline myopathy patients.

INTRODUCTION
Skeletal muscle mass represents up to 40% of the total body weight. Its maintenance is
regulated by the equilibrium between muscle growth or physiological hypertrophy, and
muscle atrophy, reflecting the balance between protein synthesis and degradation at
the cellular level. This balance is affected in pathologies such as cancer, HIV or diabetes
leading to muscle atrophy and reduced lifespan (1). Accumulation of undegraded
proteins in aggrosomes or inclusion bodies is often associated with development of
skeletal muscle myopathies, like nemaline or reducing-body myopathy (2). Indeed, there
is mounting evidence that the deregulation of protein turnover is the primary
pathogenic mechanism for some forms of skeletal myopathies. Hence, a deeper
understanding of the mechanisms that govern muscle protein degradation may
contribute to the development of treatments and prevention of these pathologies.
Muscle cells contain two major systems for protein degradation: the autophagylysosome, and the ubiquitin-proteasome systems (UPS). The latter is responsible for the
degradation of 80% of muscle proteins. The UPS requires the tagging of substrates by
poly-ubiquitin chains via an enzymatic cascade (3). First, the E1-activating enzyme
covalently attaches to ubiquitin through an ATP-driven step. Once activated, ubiquitin is
transferred to E2-conjugating enzymes. The last step requires the concerted action of
E2-enzymes and E3-ligases, which transfer ubiquitin from the E2-enzyme onto the
substrate (3). Once poly-ubiquitylated, the substrate is recognized by the proteasome
for degradation.
Cullin-RING ligases (CRL) represent the largest E3-ubiquitin ligase family in mammals (4,

5). Cullin (1-3, 4a, 4b, 5, 7, 9) proteins are nearly ubiquitously expressed (6) and
constitute the backbone of this complex. In order to form the functioning CRL complex,
each Cullin binds to one of two RING (Really Interesting New Gene) domain proteins
(Rbx1 or Rbx2) that associates with E2 conjugating enzymes. In addition, Cullins interact
with specific substrate adaptor protein families, thereby achieving specificity for a range
of cellular substrates (7). The activity of CRLs is regulated through posttranslational
modification of the Cullin backbone by the small ubiquitin-like modifier Nedd8, also
called neddylation (7). Cullin neddylation is removed by the COP9 signalosome complex,
leading to the inactivation of the CRL (8).
For the last decades, Cullin proteins were mainly studied in the context of cancer
development due to their roles in the regulation of cell proliferation through the
degradation of Cyclin proteins (9). However, data regarding their roles in other tissues
or pathologies remain poorly characterized. Few muscle-specific substrate adaptors that
interact specifically with Cullin-1, like Atrogin-1, have been intensively investigated, and
were found to exhibit key roles during muscle atrophy (10). We have recently shown
that neddylation and CRL activity is necessary for normal myoblast differentiation,
fusion and maturation in vitro (11).
Cullin-3 is highly enriched in muscle tissues (6), localizes to myofilaments and is involved
in muscle protein breakdown in adult animals (12). Cullin-3 utilizes the large family of
BTB-domain-containing proteins as substrate adaptors. A prominent subset of the BTBprotein family with roles in skeletal muscles is the BTB/Kelch-adaptor protein family,
characterized by their combination of BTB- and Kelch-repeat domains (13). Proteins of

this family are involved in a plethora of molecular and cellular mechanisms such as cell
migration, morphology or protein expression (13). Very recently, mutations in several
BTB/Kelch genes (i.e. KLHL9, KLHL40, KLHL41 and KBTBD13) were associated with the
development of distal and nemaline myopathies in patients (13-17). The early onset of
these myopathies suggests important roles for Cullin-3 and its associated protein
turnover for skeletal muscle development.
While many BTB/Kelch-domain proteins may be Cullin-3 substrate adaptors, their
substrates in skeletal muscles remain largely unknown. However, KLHL40 was recently
shown to be necessary for postnatal muscle growth through the degradation of
dimerization partner 1 (DP1) and the subsequent repression of E2F1-DP1 complex
activity (18). Unexpectedly, KLHL40 also acts as a stabilizer of the thin filament proteins
Leiomodin-3 and Nebulin (19). This last discovery suggests non-canonical functions for
the Cullin-3 E3-ligase complex that could also be important for the stabilization of some
substrate proteins rather than their degradation. These findings add a new degree of
complexity to the protein turnover mechanism related to Cullin-3. Therefore, the
discovery of new substrates for Cullin-3 during muscle development will be of great
interest for a better understanding of myogenesis and pathogenesis of associated
myopathies. While their functions are mainly unknown in muscles, expression patterns
of other BTB/Kelch-domain proteins suggest important roles during muscle
development (13). These findings represent an emerging role for Cullin-3 in muscle
homeostasis. Indeed, characterizing the specific function(s) of Cullin-3 and its related
protein turnover during muscle development would increase our understanding of

muscle biology as well as pathological mechanisms for the etiology of muscle diseases,
like nemaline myopathy.
While writing this manuscript, an article investigating the role of Cullin-3 in striated
muscles was published (20). The authors demonstrated that Cullin-3 was required for
striated muscle development, a finding that our studies fully support. However, no
molecular mechanism that explained some of the observed muscle defects were given.
We performed in-depth characterization of mice lacking Cullin-3 in skeletal muscles.
Specifically, we focused on the role of Cullin-3 for the diaphragm, a hot-spot for Cullin-3
substrate adaptor function. Our data show the importance of Cullin-3 for myoblast
fusion, differentiation and neuromuscular junction (NMJ) establishment through the
modulation of actin dynamics and the regulation of protein levels for non-muscle alphaactinin isoforms ACTN1 and ACTN4. Finally, we also found specific accumulation of
ACTN1 and ACTN4 only in the muscles of patients suffering from Cullin-3 related
nemaline myopathy, characterized by mutations in KBTBD13. In addition, our study
revealed that ACTN1 and ACTN4 are novel constituents of nemaline bodies in these
patients.

RESULTS
Generation and validation of skeletal muscle Cul3-knockout (skm-KO) mice. To explore
the role of Cullin-3 during skeletal muscle development, we crossed Cul3flox/flox mice (21)
with transgenic animals that express cre-recombinase under the control of the
myogenin promoter and the MEF2C enhancer (22) (Supplementary Figures S1A-B). The
transcript and protein levels of Cullin-3 were subsequently monitored by RT-PCR and
immunoblot analyses. Efficient recombination of the Cullin-3 gene was observed only in
skeletal muscles of Cul3flox/flox;cre+ embryos, thereafter designated as skm-KO (Figure 1A
and Supplementary Figure S1C). In diaphragms, protein levels of Cullin-3 were
diminished by 70% compared to controls (Figure 1A-B). Remaining Cullin-3 was likely
due to its expression in other cell-types that are present in skeletal muscles (e.g., blood
vessels, neural tissues or fibroblasts). Analysis of Cullin-3 protein levels in other tissues
did not reveal significant changes (Figure 1A). We did not identify changes in mRNA
levels of other Cullin family members (Supplementary Figure S1D).
Changes to global protein neddylation was assessed by immunoblot analysis, and
revealed a 45% decrease in the 80kDa band, consistent with the predicted sizes of most
Nedd8-modified Cullin proteins (23, 24) (Figure 1C-D). This substantial change suggests
that Cullin-3 represents a major constituent of all active Cullins detected in the
developing skeletal muscles. Analysis of K48-linked poly-ubiquitylated substrates, which
are normally targeted to the proteasome for degradation revealed a decrease of low
molecular weight bands (Figure 1E). Because the UPS and autophagy-lysosome system
are interconnected, we assessed p62 protein levels as marker for changes to cellular

autophagy. Levels of p62 in skm-KO were unchanged compared to controls (Figure 1E),
excluding compensatory mechanisms played by the autophagy-lysosome system to
overcome deficiency of the ubiquitin-proteasome pathway. Summarized, depletion of
Cullin-3 in our mouse model was strictly restricted to skeletal muscles and led to a
decrease in global neddylation and poly-ubiquitylation of proteins without affecting p62
expression.

Skeletal muscle expression of Cullin-3 is required for neonatal survival.
Genotype analysis of animals at weaning stage (P21) demonstrated a complete absence
of skm-KO mice (Supplementary Figure S2A). In comparison, skm-KO embryos were
present in expected mendelian ratios at embryonic stage E18.5 (Supplementary Figure
S2A). While skm-KO embryos were able to form skeletal muscles, our analyses revealed
a fully penetrant postnatal lethality phenotype. Indeed, all skm-KO embryos died within
30 minutes following C-section (Figure 2A). Skm-KO neonates show few and slow
spontaneous movements, and turned rapidly cyanotic (Figure 2B, Supplementary Figure
S2B), which was highly suggestive of respiratory defects. Analysis of their gross anatomy
revealed a strong spine curvature and wrist drop (Figure 2B), both hallmarks of muscle
weakness. To evaluate if skm-KO embryos were able to breathe, lungs were collected
and placed immediately on the surface of water. In contrast to controls, lungs of skm-KO
embryos sank, indicating that they had never been inflated (Figure 2C). Histological
analyses showed that lung alveoli of skm-KO embryos were not expanded (Figure 2D),
again indicating that skm-KO embryos were unable to breathe. Our data confirm

previous reports (20) that expression of Cullin-3 in skeletal muscles is absolutely
required for neonatal survival, and that the cause of death in skm-KO mice is due to a
breathing defect.

Loss of Cullin-3 leads to severe myopathy characterized by skeletal muscle maturation
defects and fiber hypotrophy.
Focusing on E18.5 skm-KO embryos, we found a 22.3% decrease in their body weight
compared to controls (ctl=1.35±0.02g, skm-KO=1.05±0.02g; p>0.0001; Figure 3A).
However, tibia lengths were not significantly changed (ctl=1.8±0.2cm, skmKO=1.7±0.2cm; n=5 for each genotype). These data indicate that the decrease in body
weight is not due to global prenatal growth retardation but may be more attributed to a
65% decrease in skeletal muscle mass (Figure 3B, Supplementary Figure S3A). Loss of
skeletal muscles was also observable in diaphragm and hindlimb cross-sections stained
with Hematoxylin-Eosin (Figure 3C and Supplementary Figures S3B-C). Masson’s
trichrome did not reveal abnormal fibrosis (not shown). However, Gomori’s modified
trichrome staining showed presence of aggregates (Supplementary Figure S3D). This
phenotype was reminiscent of observations made in nemaline myopathies associated
with mutations in genes encoding for substrate adaptors of Cullin-3 (13).
Because mutations in genes encoding for Cullin-3 substrate adaptors are mainly
associated with early onset myopathies (13), we hypothesized that muscle maturation
in absence of Cullin-3 may be affected. We assessed several sarcomeric proteins,
markers of mature muscles, and found a severe decrease in the expression of

sarcomeric Myosin Heavy Chain, Desmin and Filamin-C (Figure 3D, Supplementary
Figures S4A-C). We also noticed trends towards decreased expression of sarcomeric
alpha-actinin 2 (ACTN2) and increased expression of ACTN3 (Figure 3D, Supplementary
Figure S4D-E) in skm-KO diaphragms. However, none of these changes reached
significance. During development, myonuclei first locate to the center of fibers, then
migrate to the periphery in more mature muscles (25). In skm-KO, we observed a
widespread presence of centralized nuclei while they were mainly found at the
periphery in controls (Figure 3E and Figure 4A). Altogether these data are suggestive of
a muscle maturation defect.
In order to investigate the pathogenic mechanism, we assessed if the reduced muscle
mass relied on hypotrophy (a decrease in the size of the fibers) or hypoplasia (a
decrease in the number of fibers). We stained diaphragms of control and skm-KO
embryos with Wheat Germ Agglutinin (WGA) in order to delineate individual myofibers
and analyze their sizes and numbers. The mean fiber cross-sectional area (CSA) was
reduced by 62% (ctl=95±5.06µm2, skm-KO =32±1.51µm2; p<0.0001, Figure 4A and
Supplementary Figure S4F) and the distribution of fiber CSAs was shifted towards
smaller diameters in comparison with controls (Figure 4B). However, the number of
fibers constituting the diaphragm was unchanged (ctl=3076±230, skm-KO=2654±470;
Supplementary Figure S4G), suggesting that fiber hypotrophy was accountable for the
reduced muscle mass.
It is established that during early steps of muscle development, myoblast fusion
represents a limiting step for optimal myofiber size and muscle mass (26-33). We tested

if a defect in myoblast fusion could be responsible for the muscle fiber hypotrophy
observed in embryonic skm-KO diaphragms. We isolated myoblasts from E18.5 control
and skm-KO muscles and validated that skm-KO myoblasts undergo recombination of
the Cullin-3 locus upon expression of myogenin during differentiation (Figure 4C).
We then assessed myoblast fusion after 3 days of differentiation and observed a defect
in skm-KO myotube formation (Figure 4D). skm-KO myoblasts expressed myogenic
factors such as MyHC but did not form long myotubes (Figure 4D) as confirmed by the
decrease in their fusion index defined as the number of nuclei per myotube
(Supplementary Figure S4H), pointing out a fusion defect.
To confirm these results, we transfected C2C12 cells with siRNA against Cullin-3 and
monitored their differentiation. We found a 72% decrease in Cullin-3 protein levels in
cells expressing the siRNA compared to cells expressing scrambled siRNA (Figure 4E and
Supplementary Figure S4I).

We then assessed myoblast fusion 5 days after

differentiation and observed a 20% decrease in the fusion index (Figure 4F and
Supplementary Figure S4J). While muscle proteins, such as MyHC, were not significantly
changed in absence of Cullin-3, they trended towards lower expression levels (Figure 4E,
and Supplementary Figure S4I).
Summarized, our data indicate that lack of Cullin-3 impedes a step required for the
fusion of myoblasts and maturation of muscle fibers.

Absence of Cullin-3 affects proteins involved in degradation, calcium signaling,
metabolism, muscle contraction and actin modulation.

Next, we aimed at identifying molecular mechanisms underlying the muscle defects
observed in skm-KO embryos in order to better characterize Cullin-3 functions during
skeletal muscle development. While Cullin proteins, such as Cullin-1 and Cullin-3, were
broadly expressed in various adult skeletal muscles, diaphragm was a hot spot for BTBdomain proteins (Cullin-3 substrate adaptors) including KBTBD5, KBTBD13, KLHL9,
KCTD6 and PLZF, with the exception of KCTD9 (Figure 5A). To maximize the chances for
identifying substrates of Cullin-3 and changes to proteins that may be responsible for
the observed phenotype, we performed an unbiased large-scale proteome analysis
using E18.5 diaphragms. Our analysis revealed that 6% of detected proteins were
significantly altered in absence of Cullin-3 (Supplementary Figure S5A). Among those, 26
proteins were significantly accumulated in skm-KO diaphragms, while 100 were
significantly down regulated (Figure 5B).
Functional analyses aided by DAVID (https://david.ncifcrf.gov) and Metascape
(http://metascape.org/) revealed that deregulated proteins might be grouped into five
categories: heat shock proteins and degradation pathways, muscle and calcium
associated proteins, proteins associated with metabolism and mitochondria,
ribonucleoproteins and DNA-associated proteins, and proteins involved in actin
modulation (Figure 5B, Supplementary Figures S5B-D). Of note, KLHL41 and KLHL31, two
substrate adaptors involved in muscle physiology (15, 34, 35) were strongly decreased in
skm-KO muscles (Supplementary Figure S5D), suggesting a destabilization of these
proteins in absence of Cullin-3. Altered proteins involved in muscle and calcium
physiology, metabolism and mitochondria, HSP and degradation pathways were mainly

down-regulated, whilst ribonucleoproteins and DNA-associated proteins were
accumulated. To validate our proteome analysis, we studied the expression of
mitochondrial subunits by immunoblot analysis using the OxPhos antibody cocktail. A
strong decrease in almost all mitochondrial complex subunits was confirmed in skm-KO
diaphragms (Supplementary Figure S5C), validating our proteome analysis.

Cullin-3 knockout muscle cells accumulate non-muscle isoforms of alpha-Actinin.
A surprising result was the strong deregulation of proteins involved in actin cytoskeleton
modulation. Actin binding proteins were found both, accumulated and downregulated
in skm-KO diaphragms (Figure 5B-C). Because of the pivotal role that remodeling of the
actin cytoskeleton plays for muscle development, including myoblast fusion (36, 37), we
decided to focus on these proteins.
Among them, non-muscle ACTN1 and ACTN4 isoforms were the most significantly
accumulated. ACTN4s role in skeletal muscles has been investigated. Surprisingly,
ACTN4 overexpression seemed to enhance myoblast differentiation (38). Hence, we
focused on the role that ACTN1 may play in our phenotype.
We first confirmed the accumulation of ACTN1 in knockout muscles (Figures 6A-B) using
an antibody that has been validated on muscle cells transfected with siRNA against
ACTN1 (Supplementary Figure S6A). In skm-KO myoblasts, we also observed
accumulation of ACTN1 during differentiation (Figure 6C-D), suggesting that
accumulation of ACTN1 in the skeletal muscles of Cullin-3 knockouts originated from
muscle cells, and not from other non-muscle tissues. Intriguingly, we observed a similar

result in muscles of HSA-cre inducible Cullin-3 knockout (iCul3-KO) mice. Loss of Cullin-3
in adult muscles 1 month after excision of the gene by doxycycline treatment resulted in
the accumulation of ACTN1, while sarcomeric ACTN2 remained unchanged (Figure 6E-F).
Altogether, our data indicate that Cullin-3 ablation in muscle cells is responsible for the
accumulation of ACTN1.

We then investigated the role that ACTN1 may play during early muscle differentiation.
First, we monitored the expression of ACTN1 at the RNA and protein levels during C2C12
differentiation. While sarcomeric ACTN2 increased during differentiation, we found that
ACTN1 and ACTN4 were down regulated (Supplementary Figures S6B-C). However, RNA
levels of Actn1 remained unchanged during differentiation (Supplementary Figure S6D).
This result suggested an active regulation of ACTN1 protein levels and a role for Cullin-3
during muscle cell differentiation. In proliferative C2C12 cells, ACTN1 localized at the
edge of the cells and along the actin stress fibers and focal contacts, confirming previous
data in other cell types ((39) and Supplementary Figure S6E). Three days after
differentiation, when myoblast fusion occurs, ACTN1 staining became more fragmented
in a subset of cells. In other cells, it retained its localization along actin stress fibers and
focal adhesion contacts (Supplementary Figure S6E). Finally, five days after
differentiation, while ACTN1 still localized at the edge of mono-nucleated and non-fused
cells, it was weakly expressed and diffusely localized in the cytoplasm of myotubes.
Altogether, these data suggest a very active and intense remodeling of ACTN1 during
myogenesis and myoblast fusion.

Overexpression of ACTN1 in differentiating myoblasts leads to fusion defects.
To test our hypothesis of a causal role for the abnormal accumulation of ACTN1 and the
pathological modulation of the actin cytoskeleton proteins in the phenotype of skm-KO
embryos, we generated a C2C12 cell line that stably overexpresses HA-ACTN1. We first
validated the correct expression of HA-ACTN1 in C2C12 (Figure 7A and Supplementary
Figure S7A) and monitored their differentiation. Five days after differentiation, HAACTN1 overexpressing cells displayed a reduction in the ability to form myotubes,
compared to control cells (Figure 7B), accompanied by a slight but consistent decrease
of MyHC expression (Figure 7A and Supplementary Figure S7B). Our analyses indicated a
44% decrease in the fusion index of HA-ACTN1 cells compared to controls (Figure 7C)
due to an over-representation of small myotubes (2-4 nuclei), and an almost complete
loss of myotubes containing larger amounts of nuclei (≥54 nuclei) (Figure 7D).
Altogether our data suggest that accumulation of ACTN1 impaired the fusion of
differentiating myoblasts, resulting in smaller myotubes. These findings were
reminiscent of the phenotype of muscle fibers and satellite cells from Cullin-3 knockout
animals, suggesting that accumulation of ACTN1 is responsible for, at least, part of the
phenotype observed in Cullin-3 depleted tissues.

Cullin-RING ligase activity is increased during Acetylcholine receptor (AchR) clustering
and leads to the increase of poly-ubiquitylated proteins.

Impairment of NMJ development often results in respiratory defects due to the
dysfunction of the diaphragm and intercostal muscles (40). Importantly, a striking
sustained and beneficial effect of acetylcholine-esterase inhibitor treatment has been
observed in a patient affected by KLHL40-related nemaline myopathy, another
confirmed substrate adaptor for Cullin-3 (41). In addition, sarcomeric ACTN2 has been
shown to interact with rapsyn (42), and active actin cytoskeleton remodeling is
absolutely required for proper Acetylcholine receptor (AchR) clustering and NMJ
development (43).
Cullin E3-ligase activity is required for normal AchR clustering in vitro (11, 44).
We first monitored Cullin-3 expression following stimulation of C2C12 myotubes with
neural agrin. We observed that Cullin-3 was significantly increased upon AchR clustering
(Figure 8A and Supplementary Figure S8A), suggesting a role during NMJ development.
We then looked at the expression pattern of Nedd8, the marker for Cullin activity,
during AchR clustering. Following 48 hours of agrin stimulation, we found a strong
increase in Nedd8 levels at 80 kDa (Figure 8B and Supplementary Figure S8B), suggesting
an increase in Cullin E3-ligase activity during this process. We also observed a significant
increase in poly-ubiquitylated proteins (Figure 8C and Supplementary Figure S8C),
indicating an increase in protein degradation during AchR clustering. In order to test if
the increase of poly-ubiquitylation was due to the increase in Cullin E3-ligase activity,
we treated myotubes with both, agrin and MLN4924 (a CRL inhibitor). In absence of
Cullin activity, as shown by the loss of Nedd8 signal around 80kDa (Figure 8D, left
panel), the global increase of poly-ubiquitylation observed in control conditions was

inhibited (Figure 8D, right panel) demonstrating a causal role for CRLs in the increase of
poly-ubiquitylation during AchR clustering. Altogether, these data indicate that Cullin-3
is increased during AchR clustering in vitro and that increased Cullin activity is in part
responsible for protein degradation during AchR clustering.

Following these results, we decided to assess NMJs in vivo, specifically focusing on
organization

and

AchR

clustering

in

skm-KO

diaphragms.

We

performed

immunofluorescence analyses of post- and pre-synaptic elements. Our data revealed a
complete disorganization of the NMJs in muscle lacking Cullin-3 (Figure 9A). While AchR
clusters were aligned along a narrow band in the center of embryonic control
diaphragms, they appeared scattered in skm-KO diaphragms (Figure 9A). In addition,
staining

of

Synaptophysin/Neurofilament

indicated

abnormal

branching

and

arborization of the motoneuron (Figure 9A-B), likely due to the mislocalization of the
AchR clusters. Quantification showed almost a 4 times increase of the motor endplate
width in skm-KO diaphragms, without altering the percentage of innervated AchRs
clusters (Figure 9C). These data suggest that the motoneuron, while hyper-arborized
and branched, was able to connect with the post-synaptic element during muscle
development. We also noticed that AchR clusters were smaller in diaphragms of skm-KO
embryos compared to controls (Figure 9D) due to an overrepresentation of small
clusters and the absence of large ones.
Because we showed previously that loss of Cullin-3 leads to an accumulation of ACTN1
in muscles, we assessed if ACTN1 overexpression could be responsible for the NMJ

phenotype. We differentiated C2C12 overexpressing HA-ACTN1 or HA for 5 days,
followed by agrin-induced AchR clustering. Analysis of cluster-size distribution showed a
shift towards accumulation of small clusters and an absence of large ones in HA-ACTN1
expressing cells (Figure 9E), which is reminiscent of the observations made in the
diaphragms of skm-KO embryos. In addition, a 21% decrease in the average AchR cluster
length was found in myotubes expressing HA-ACTN1 (Supplementary Figure S8D-E).
Altogether, these data suggest that Cullin-3 is required for normal NMJ development
and that accumulation of ACTN1 affects the formation of AchR clusters.

Non-muscle alpha-Actinins are specifically accumulated in muscles of Cullin-3 related
nemaline myopathy patients
Mutations in several substrate adaptors for Cullin-3 (i.e. KBTBD13, KLHL9, KLHL40,
KLHL41) are associated with the development of distal and nemaline myopathies (1317). In order to test the relevance of our findings for human health, we analyzed muscle
samples from nemaline myopathy patients with mutations in the Cullin-3 substrate
adaptor

KBTBD13

(16),

NM_003289.3(TPM2):c.443T>C)

or

TPM2
NEB

(Chr9(GRCh37):g.35685480A>G,

(chr2:152389953T>C,

c.21522+3A>G

(NM_001271208.1); chr2:152581433delG, c.445delC (NM_001271208.1)). Mutations in
KBTBD13 are mainly associated with early onset nemaline myopathies, characterized by
muscle weakness, slow movement, pronounced muscle fiber atrophy and the presence
of nemaline bodies (16). KBTBD13 is a substrate adaptor for Cullin-3 (45). We confirmed
the presence of nemaline bodies in our KBTBD13 patients through Gomori trichrome

staining (Figure 10A). We then investigated protein levels of Actinin isoforms. While
levels of ACTN2 and ACTN3 were mainly unchanged across the patients and controls, we
found a striking increase in ACTN1 and ACTN4 levels only in KBTBD13 patients (Figure
10B), mimicking results obtained in the muscles of skm-KO embryos. Finally, we asked if
nemaline bodies, features shared by all nemaline myopathy patients are positive for
non-muscle alpha-Actinin isoforms. While, nemaline bodies are known to be positive for
ACTN2, we found that they were also reactive to ACTN1 and ACTN4 in muscle biopsies
of KBTBD13 patients (Figure 10C).
Altogether, these data reveal an abnormal accumulation of non-muscle ACTN1 and
ACTN4 in nemaline myopathy patients with mutations in KBTBD13, which encodes for a
Cullin-3 related protein. In addition, we unravel that ACTN1 and ACTN4 accumulate in
nemaline bodies of these patients, lengthening the list of proteins constituting these
structures.

DISCUSSION
It has been recently shown that mice lacking Cullin-3 develop severe muscle atrophy
and cardiomyopathy but the responsible molecular mechanism has not been identified
(20).
While Nedd8, the crucial regulator for CRL activity is largely downregulated in a lot of
mature tissues, its expression remains high in differentiated muscles (i.e. heart and
skeletal muscles) (24), suggesting important roles for CRLs in these tissues. Our data
show for the first time that substrate adaptors of Cullin-3 display diverse expression
patterns in various skeletal muscle types, with diaphragm muscles emerging as a
hotspot for their expression. Absence of Cullin-3 impairs the UPS, and is characterized
by a decrease in protein neddylation and poly-ubiquitylation, in differentiating skeletal
muscles. These findings suggest that Cullin-3 is a major active CRL during muscle
development.
Cullin-3 skm-KO mice exhibit severe hypotrophy of myofibers and die within a few
minutes after birth. Cullin-3 depleted myoblasts (skm-KO satellite cells and C2C12
treated with Cullin-3 siRNA), while able to express myogenic factors, were unable to
form large myotubes, suggestive of impaired myoblast fusion. Comparisons with mouse
models exhibiting a similar phenotype indicate that muscle hypotrophy and fusion
defects may be, at least, partially responsible for the death of Cullin-3 skm-KO mice (2633).

Intriguingly, skm-KO embryos share a similar phenotype with some knockout models for
NMJ components, such as Agrin, Choline acetyltransferase, MuSK or Rapsyn (40). The
models are characterized by rapid postnatal lethality due to respiratory defects resulting
from insufficient muscle development and improper transmission of neuronal signals to
the muscle (40). Due to the striking beneficial effects of acetylcholine-esterase inhibitor
treatment in a KLHL40-related nemaline myopathy patient (41), we asked if Cullin-3
could also be required for NMJ formation and function. Our data uncovered a new
function for Cullin-3 during development of NMJs, an essential process for myogenesis
and muscle growth (40). We demonstrated that Cullin-3 and CRL activity increases
during AchR clustering, and is required for the increased level of poly-ubiquitylated
proteins occurring during this process. Increasing evidence suggests that protein
ubiquitylation may play an important role in regulating synapse development (46).
Interestingly, it was demonstrated that RPY-1, the homolog of Rapsyn in C. elegans, can
be degraded by Cullin-3 (47, 48). While those findings link Cullin-3 with NMJ
development in nematodes, this mechanism has not been further investigated in
mammals.
In this study, we found that loss of Cullin-3 in vivo an in vitro led to disorganized and
smaller AchR clusters, resulting in hyper-arborization of the motoneuron. Of note,
Cullin-5 and -2 have already been linked to the development of NMJs in Drosophila
melanogaster, but their roles have also never been further corroborated in mammals
(49). Altogether, these data may uncover a more universal function for CRLs during NMJ
development.

On the molecular level, our proteome analysis of diaphragm muscles revealed the
deregulation of proteins involved in muscle metabolism and mitochondria, calcium
handling,

protein

degradation,

actin

cytoskeleton

modulation,

as

well

as

ribonucleosome and DNA-associated proteins. Our proteome analysis diverges from the
recently published Cullin-3 knockout model (20). An explanation for this discrepancy is
that the authors performed proteome analysis of whole hindlimb muscles, while we
specifically isolated and investigated the diaphragm. We chose to use diaphragm over
hindlimb muscles for several reasons: 1) the diaphragm is a hot-spot for the expression
of Cullin-3 substrate adaptors, increasing the chances to identify molecular mechanisms
played by Cullin-3 in skeletal muscles. 2) In contrast to hindlimbs, the use and analysis of
diaphragm muscles reduces contamination by other tissue types, minimizing the risks of
identifying changes that are actually due to non-muscle cells, such as fibroblasts from
connective tissue, adipocytes or endothelial cells.
The deregulation of non-muscle ACTN1 and ACTN4, Vinculin, Filamin-C, Cofilin-2,
Myotilin or Xirp1 triggered our attention. Cullin-3 and BTB-domain containing proteins
have already been shown to act as organizers of the cytoskeleton in Drosophila
melanogaster (50, 51). The remodeling of the actin cytoskeleton is an essential step for
efficient myoblast fusion (37) and for AchR clustering at the NMJ (52, 53). While
Vinculin, Filamin-C, Cofilin-2 and Myotilin have been associated with myoblast fusion
and differentiation (54-57) and NMJ (58, 59), little is known about the role of ACTN1 in
muscles.

The family of alpha-Actinin proteins includes the muscle specific ACTN2 and ACTN3, and
two non-muscle isoforms ACTN1 and ACTN4. Alpha-Actinins are essential for the
stability and the architecture of the cytoskeleton, and mutations in these genes lead to
pathologies in humans (60-62). ACTN1 and ACTN4 crosslink actin filaments in the
cytoskeleton of non-muscle cells, while sarcomeric ACTN2 and ACTN3 anchor the thinfilaments and titin at the Z-disks of mature muscles (39). Alpha-Actinins form homo- or
heterodimers and each dimer binds to common or specific ligands (63, 64), suggesting
specific biological roles. In this study, we show that during normal myoblast
differentiation ACTN2 and ACTN3 are up-regulated, while ACTN1 and ACTN4 are
downregulated. In contrast to sarcomeric isoforms, the non-muscle isoforms have been
poorly investigated in developing muscles (39). ACTN4 seems to enhance differentiation
of C2C12 myoblasts through the regulation of myogenic genes (38). Here, we show that
the loss of Cullin-3 in muscle cells results in accumulation of non-muscle ACTN1.
Overexpression of ACTN1 in myoblasts was sufficient to recapitulate most of the
phenotype of skm-KO cells, characterized by fusion and AchR clustering defects as well
as myofiber hypotrophy, suggesting that ACTN1 and ACTN4 play different, even
opposite roles in developing muscles. Contrasting roles for ACTN1 and ACTN4 have
already been described in other tissues (65-67), as well as differential biochemical
properties in muscles (68). The post-synaptic component of the phenotype of our model
reveals novel roles for Cullin-3 targeted protein turnover and ACTN1 regulation during
NMJ formation.

Mutations in Cullin-3 substrate adaptors genes such as KBTBD13 have been associated
with early onset nemaline myopathies. Nemaline myopathies are characterized by
nemaline bodies (protein aggregates) in myofibers, and are often associated with
muscle weakness (69). Proteins constituting nemaline bodies include Actin (70), FilaminC (71), Telethonin (72), Myozenin (73), Myopalladin (74) or Myotilin (75). While
sarcomeric ACTN2 is also thought to be a major constituent (71, 76, 77), studies
investigating whether levels of muscle alpha-Actinins are changed in these patients
show conflicting results, depending on the used method, and whether the employed
antibodies have been specific to one alpha-Actinin isoform (76-79). Non-muscle ACTN1
and ACTN4 have never been investigated per se in nemaline myopathy patients but
abnormal deposition of ACTN1 proteins in clusters has been observed in cardiomyocytes
from patients with dilated cardiomyopathy or chronic pressure overload (80),
representing a biomarker for the disease. While these data do not demonstrate that
ACTN1 accumulation is causative for the cardiac disease, they are suggestive of an
involvement in the pathogenic mechanism. In addition, ACTN1 interacts with UDP-Nacetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), an enzyme linked
to hereditary inclusion body myopathy (HIBM)(81).
Our data show that ACTN1 and ACTN4 were accumulated in muscle tissues and
nemaline bodies of patients with mutations in KBTBD13 but not in TPM2 and Nebulin.
Those results suggest that accumulation of ACTN1 and ACTN4 may represent a specific
pathogenic mechanism due to Cullin-3 impairment.

While further studies are required to know the extent of non-muscle alpha-Actinin
expression in nemaline myopathy patients, ACTN1 and ACTN4 should now be
considered as constituents of nemaline bodies in some patients.
Indeed, a correlation between ACTN1 or ACTN4 protein levels and severity of the
disease would be of clinical interest. An interesting feature of patients with KBTBD13
mutation resides in the lack of cardiac phenotype (16). In contrast to skeletal muscles,
heart development does not rely on cell fusion events. This developmental difference
may contribute to protecting the heart from the consequences of ACTN1 accumulation.

To summarize, we propose that Cullin-3 critically contributes to actin cytoskeleton
remodeling to allow for optimal myoblast fusion, differentiation and clustering of AchRs.
We propose that non-muscle ACTN1 and ACTN4 are a new target for Cullin-3 during
myogenesis. Mutations in Cullin-3 substrate adaptors such as KBTBD13, leads to
pathological non-muscle Actinin accumulation in patients (Figure 11). This finding may
represent a new unifying pathogenic mechanism for the etiology of Cullin-3 related
myopathies. Further investigations regarding a potential accumulation of non-muscle
alpha-Actinins in nemaline patients with mutations in other Cullin-3 substrate adaptors
(e.g. KLHL9, KLHL40 and KLHL41) will be required to confirm this hypothesis.

METHODS
Generation of skm-Cul3 and iCul3-KO mice
The strategy used to generate the floxed-Cul3 mice has been described and published
(21). We generated constitutive skeletal muscle specific (skmKO-Cul3) and inducible
skeletal muscle specific (iCul3-KO) Cullin-3 knockouts, by breeding floxed-Cul3 mice with
mice expressing the Cre-recombinase under control of the Myogenin promoter (22), or
a tetracycline/doxycycline inducible human skeletal actin (HSA) promoter (82),
respectively. All procedures involving genetically modified animals have been approved
by the UC San Diego Institutional Animal Care and Use Committee (IACUC).
Extraction of total RNA, RT-PCR and qRT-PCR analysis
Mouse muscle samples were snap frozen in liquid nitrogen and stored at -80°C. Cells
were washed with PBS, then lysed using TRIzol reagent (ThermoFisher Scientific). Total
RNA from muscles or cells was extracted according to the manufacturers instructions.
Purity of RNA was assessed by a ratio of absorbance at 260nm and 230nm >1.7. 200ng
of RNA was used for reverse transcriptase reaction using the Maxima First Strand cDNA
synthesis

kit

(Fermentas;

ThermoFisher

Scientific)

and

random

hexamers.

Oligonucleotides for RT-PCR and RT-qPCR are listed in Supplementary Table 1.
Oligonucleotides optimized for qPCR of murine Actinin1 and cyclophilin B were used in
reactions employing the PerfeCTa SYBR green real-time qPCR mix (Quanta BioSciences;
Beverly, MA) and a CFX96 thermocycler (BioRad; Hercules, CA). Samples were

normalized to cyclophilin B. If not noted otherwise, three biological samples were
analyzed per sample group.
C2C12 and primary myoblast cell culture
C2C12 cells were grown, differentiated and their fusion index was assessed as described
previously (26).
Mouse primary myoblasts were obtained by dissecting the diaphragm and tongue
muscles from E18.5 embryos. Myoblasts were isolated and cultured as previously
described (11).
siRNA
Proliferating C2C12 cells were transfected with siRNA directed against Cullin-3 (ONTARGETplus mouse Cullin-3 (26554); GE Healthcare Dharmacon), ACTN1 (ONTARGETplus mouse Actn1 (L-066191-00-0005) or scrambled control (ON-TARGETplus
non-targeting siRNA #1; GE Healthcare Dharmacon) using DharmaFECT 1 transfection
reagent (GE Healthcare Dharmacon) according to the manufacturers instructions. 24
hours after transfection, cells were changed into differentiation medium, and allowed to
differentiate for 5 days before analysis. Efficiency of siRNA was verified by immunoblot
analysis.

Immunoblot analysis
Proteins were extracted from tissues and cells then quantified as previously described

(11). 5 to 10μg of clarified lysates were separated by SDS-PAGE. Transfer was performed
on nitrocellulose membranes (BioRad). Membranes were incubated with blocking
solution (TBS-Tween containing 5% BSA) for 1 hour at room temperature, then
incubated with primary antibodies (Supplementary Table 2) in blocking solution
overnight at 4°C. After washing, secondary HRP-linked antibodies (DAKO, Cell Signaling)
were applied for 1 hour at room temperature. After washing, antibody-bound proteins
were visualized on X-ray films or by BioRAD imager. Quantification of band intensities
was performed using ImageJ software (1.48v) or BioRAD Image Lab (v5.2.1). Uncut
immunoblot images can be found in the supplementary data section.
Quantitative proteome analysis of skeletal muscle
Proteins were isolated form diaphragms by lysis into ice-cold isolation buffer (300mM
KCl, 30mM PIPES pH6.6, 0.5% NP-40, 1x protease inhibitor (Roche), 1x Phos-Stop
(Roche)). Insoluble proteins were removed by centrifugation (14,000 rpm, 10 minutes at
4ºC), and the supernatant was diluted 1:4 with ice cold dilution buffer (1x Phos-Stop
(Roche), 0.5% NP-40, 1mM DTT). Precipitation of acto-myosin components was done by
centrifugation (14,000rpm, 15 minutes at 4ºC), and the remaining supernatant snapfrozen for further analysis by mass-spectrometry.
Proteins destined for mass-spectrometry were digested by tryptic digest, differentially
labeled for iTRAQ and analyzed in a SciEx QTOF5600 system. Collected spectrograms
were further analyzed and quantified using Peaks (83). A full dataset of identified
proteins was deposited at the Mendeley repository (84). Bioinformatic enrichment and

pathway analysis was done using Metascape (http://metascape.org/; (85)), Morpheus
(https://software.broadinstitute.org/morpheus/), the BioGRID (https://thebiogrid.org/;
(86)) and Venny (http://bioinfogp.cnb.csic.es/tools/venny).

Statistical analysis
With the exception for built in statistics by Peaks Studio software, statistical analysis of
all data was done by either using ANOVA comparison followed by correction for
multiplicity of testing using Bonferroni's multiple comparisons test, or unpaired t-test,
performed using Excel (Microsoft) or GraphPad Prism version 7 for Mac (GraphPad
Software, http://www.graphpad.com/). Results are presented as means ± standard
error. P-values of p<0.05 were considered statistically significant. Sample sizes are
indicated in the figure or figure legend. If not state otherwise, both sexes were analyzed
in the experimental procedures.
Generation of HA-ACTN1 stable cell line
For expression of HA-ACTN1 in C2C12 cells, cDNA was isolated by RT-PCR on mRNA
extracted from proliferative C2C12. Oligonucleotides used for amplification were the
following:

ACTN1.fwd:

GATGGCTAGCATGGACCATTATGATTCCCAG;

ACTN1.rev:

CATGAGCTCGAGGTCGCTCTCGCCATACAG. PCR products were cloned into a custom built
HA-vector (12). HA-ACTN1 or HA-control transfected cells were selected with G-418
(Invitrogen). Plasmid expression was checked by RT-qPCR, immunoblot and
immunostaining.

Immunofluorescence microscopy
Cells were rinsed one time with PBS, fixed for 15 minutes with 4% paraformaldehyde
and rinsed 3 times with PBS. Mouse muscles were snap-frozen in isopentane cooled in
liquid nitrogen and stored at −80 °C until sectioning. Muscles were sectioned using a
Leica cryostat. Sections were fixed in ice-cold acetone for 5 minutes, followed by
rehydration in 1x PBS for 10 minutes. Cells or muscle slides were then permeabilized for
10 minutes in 1xPBS supplemented with 0.2% Triton X-100 (Sigma Aldrich; St. Louis,
MO), washed 3 times with PBS and incubated in blocking solution (Gold Buffer [GB,
150mM NaCl, 20mM Tris pH7.4] supplemented with 1% BSA) for 1 hour at room
temperature before incubation with primary antibodies (Supplementary Table 2) in
blocking solution. Primary antibodies were either incubated for 2 hours at room
temperature, or overnight at 4°C. Following incubation, cells were washed three times
for 5 minutes with PBS, and incubated with secondary antibodies (all from Jackson
ImmunoResearch Laboratories Inc.; West Grove, PA) diluted into blocking solution for 1
hour at room temperature. Secondary antibody mixtures also contained DAPI (4’, 6’
diamidino-2-phenylindol) and/or fluorescently linked alpha-bungarotoxin (BGTX;
Molecular Probes, ThermoFisher Scientific), Alexa Fluor 555 conjugate of wheat germ
agglutinin (WGA; ThermoFisher Scientific) or fluorescently labeled phalloidin (Molecular
Probes; ThermoFisher Scientific) when appropriate. After washing three times with PBS
for 5 minutes, cells were mounted using fluorescent mounting medium (Dako;
Carpinteria, CA). Microscopy was performed using an Olympus FV1000 confocal

microscope using either the 20x air objective, the 40x or 63x oil immersion objective,
zoom rates between 1 and 3, and imaged in sequential scanning mode. Images were
analyzed using ImageJ (NIH).
Stimulation of AchR clustering and quantification in C2C12 myotubes
Stimulation and quantification of AchR clustering by rat agrin (R&D Systems) was
performed as described previously (11).
Histology analyses
Transverse-sections (10 µm thickness) were stained with hematoxylin-eosin (H&E; Sigma
Aldrich) or Gomori’s modified Trichrome (VWR). Diameter and distribution of myofibers
were determined. Quantification of fiber numbers, sizes or nuclear localization was
performed on 3 sections separated by at least 30 µm. Morphometric quantification and
evaluation of fiber sizes and numbers was done using ImageJ (1.48v).

Human ethics approval
Samples from patients and controls were obtained after receiving informed consent for
diagnostic and research investigation. Studies were performed in accordance with the
Declaration of Helsinki and approved by the respective human research institutional
review board responsible for each research site.
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FIGURES AND FIGURE LEGENDS

Figure 1. Deletion of Cullin-3 in skeletal muscles affects the ubiquitin-proteasome
system.
(A) Immunoblot analysis showing loss of Cullin-3 protein only in skeletal muscle (sk.
muscle) of E18.5 skm-KO. (B) Quantification of Cullin-3 protein levels in E18.5 skeletal
muscles (n=3 for each genotype). * P<0.05 by two-tailed t-test. (C) Immunoblot analysis
showing a decrease in NEDD8 associated proteins in E18.5 skeletal muscles of skm-KO.
(D) Quantification of 80KDa NEDD8 associated proteins level in E18.5 skeletal muscles
(n=3 for each genotype). ** P<0.01 by two-tailed t-test (E) Immunoblot analysis showing
a decrease in low molecular weights of K48-ubiquitin associated proteins and no change
in p62 expression levels in skeletal muscles of E18.5 skm-KO.

Figure 2. Loss of Cullin-3 during skeletal muscle development leads to postnatal death
and respiratory defects.
(A) Survival curve of E18.5 embryos following C-section (n=23 for ctl and n=20 for skmKO). **** P<0.0001 by log rank (Mantel-cox) and Gehan-Breslow-Wilcoxon tests. (B)
Representative pictures of E18.5 embryos showing cyanosis and kyphosis of skm-KO. (C)
Floating assay using lungs extracted from E18.5 skm-KO embryos and controls 5 minutes
after the C-section and placed at the surface of water (n=18 for ctl and n=13 for skm-

KO). (D) Cross-section of E18.5 lungs 5 minutes after C-section and stained with
Hematoxylin-Eosin revealing collapsed alveoli in skm-KO embryos.

Figure 3. Absence of Cullin-3 leads to severe skeletal muscle myopathy.
(A) Body weight analysis of E18.5 embryos (n=43 for ctl, n=79 for heterozygous
(f/+;cre+) and n=41 for skm-KO). ****P<0.001 by Anova and Bonferroni's multiple
comparisons test. (B) Diaphragm weight analysis revealing a strong muscle atrophy of
E18.5 skm-KO embryos. (n=10 for ctl, n=19 for heterozygous (f/+;cre+) and n=8 for skmKO). ***P<0.0001 by Anova and Bonferroni's multiple comparisons test. (C) Crosssection of E18.5 diaphragms stained with Hematoxylin-Eosin showing a thinner muscle
in skm-KO. Scale bar = 1mm. (D) Immunoblot analysis unraveling a decrease in
expression of muscle maturation markers in skm-KO diaphragms (n=3 for each
genotype). (E) Immunofluorescence staining of diaphragm myofibers with muscle

ACTN2 and ACTN3 antibodies as well as DAPI. Arrowheads indicate centralized nuclei.
Scale bar = 20µm.

Figure 4. Loss of Cullin-3 leads to muscle fiber hypotrophy in vivo and myoblast fusion
defect in vitro. (A) Immunofluorescence staining of E18.5 diaphragms with WGA and
DAPI revealing hypotrophy of the myofibers of skm-KO. Arrowheads indicate centralized
nuclei. Scale bar = 100µm. (B) Distribution of fibers constituting diaphragms of E18.5 ctl
and skm-KO depending on their cross-sectional area (CSA in µm2) (n=3 embryos for each
genotype and >11554 fibers per genotype). (C) RT-PCR analysis of Cullin-3 and
Cyclophilin B (CycloB) in satellite cells isolated from E18.5 ctl and skm-KO diaphragms
over 3 days of differentiation in culture. Pro: Proliferation; D1-3: Differentiation day 1 to
3. (D) Immunofluorescence of satellite cells fixed after three days of differentiation and
stained with MyHC and β-Actin antibodies. Scale bar = 100µm. (E) Immunoblots of

Cullin-3, MyHC and β-Actin on C2C12 myotubes transfected with a siRNA against Cullin-3
or a scrambled siRNA, showing efficient knockdown. (F) Fusion index (number of nuclei
per myotube) of C2C12 cells transfected with a Cullin-3 or a scrambled siRNA and
differentiated for 5 days (n=3 per condition and >144 myotubes analyzed per
experiment). ****P<0.05 by two-tailed t-test.

Figure 5. Diaphragm muscle is a hot spot for Cullin-3 substrate adaptors and depletion
of Cullin-3 leads to deregulation of protein levels.
(A) Immunoblot analysis showing the pattern of expression of Cullin-1, Cullin-3 and
select Cullin-3 substrate adaptors in various mouse skeletal muscles. Myomesin-3 (87)
was used as fiber-type marker. Gas: Gastrocnemius; Sth: sternohyoideus; Pem:
pectoralis major; Dia: diaphragm; IO: internal oblique; Pei: pectoralis minor; Mas:
massester; Tri: triceps, Bib: biceps brachii; Cla: clavotrapezius; EDL: extensor digitorum
longus; TA: tibialis anterior; Ste: sternomastoideus; Sol: soleus. (B) Volcano plot of all
identified deregulated proteins in E18.5 diaphragms of skm-KO following iTRAQ mass
spectrometry (3 diaphragms have been pooled per sample and 3 samples for each
genotype have been analyzed). (C) Volcano plot highlighting deregulated proteins
involved in actin cytoskeleton-modulation as well as proteins related to muscle and

calcium handling (3 diaphragms have been pooled per sample and 3 samples for each
genotype have been analyzed).

Figure 7. Overexpression of ACTN1 in muscle cells leads to differentiation defects.
(A) Immunoblot analysis showing overexpression of ACTN1 in C2C12 cells
overexpressing HA-ACTN1 construct. Pro: proliferation; D5: differentiation day 5. (B)
Immunofluorescence staining of HA (ctl) and HA-ACTN1 overexpressing myotubes with
sarcomeric myosin antibody and DAPI after 5 days of differentiation. Scale bar = 200µm.
(C) Fusion index of cells expressing HA (ctl) and HA-ACTN1 constructs five days after
differentiation showing a decrease in the number of nuclei per myotube (n=3 for each
condition). **P<0.01 by two-tailed t-test. (D) Distribution of myotubes depending on the
number of nuclei (n=3 for each condition).

Figure 8. Cullin-3 protein levels and Cullin-RING ligase activity are increased over AchR
clustering in vitro.
(A) Immunoblot analysis showing increased expression of Cullin-3 protein levels in
C2C12 cells stimulated with neural agrin (0.5µg/mL) for 48 hours in order to trigger
acetylcholine receptor (AchR) clustering. (B) Immunoblot analysis showing increased
neddylated proteins in C2C12 cells stimulated with agrin for 48 hours. (C) Immunoblot
analysis showing increased levels of poly-ubiquitylated proteins (K48-linked) in C2C12
myotubes stimulated with agrin for 48 hours. (D) Immunoblot analyses showing a
decrease in both, Nedd8–linked and poly-ubiquitylated proteins in C2C12 myotubes
stimulated with agrin and treated with MLN4924 compared to DMSO.

Figure 9. Cullin-3 is required for normal neuromuscular junction (NMJ) formation and
acetylcholine receptor (AchR) clustering. (A, B) Immunofluorescence staining of the
pre- and postsynaptic elements of E18.5 NMJs in ctl and skm-KO diaphragms with
antibodies against Neurofilament and Synaptophysin (NF/Syn) and fluorescent
Bungarotoxin (BGTX) showing (A) increased area of the motor endplate, dispersion of
AchR clusters across the diaphragm and hyper-arborization of the motoneuron in skmKO, but (B) normal innervation of the NMJ. (A) Scale bar = 100µm. (B) Scale bar = 20µm.
(C) Quantification of NMJ endplate widths (left panel; Box and whiskers plot showing
min to max values; average is shown as +) and innervated AchRs (right panel) in the
diaphragms of ctl and skm-KO (n=3 embryos for each genotype, >895 AchRs per
genotype). ****P<0.0001, by two-tailed t-test (left panel); P=0.211 by two-tailed t-test

(right panel). (D) Distribution of AchR clusters of ctl and skm-KO diaphragms depending
on their area (n=3 embryos for each genotype). (E) Distribution of AchR cluster areas in
5 day differentiated myotubes expressing HA (ctl) or HA-ACTN1 (n=3 per condition and
>817 AchR clusters were analyzed per condition).

Figure 10. Specific accumulation of non-muscle alpha-Actinins in muscle tissues of
patients with Cul3-related nemaline myopathies. (A) Gomori Trichrome stain of
skeletal muscle cross-sections from a healthy individual and a patient with a mutation in
KBTBD13. (B) Immunoblot analyses of alpha-Actinin isoforms expression levels in
skeletal muscle biopsies from nemaline patients (NM patients; lane 1: TPM2 mutation;
lane 2: NEB mutation), patients with mutations in KBTBD13 (lanes 3 and 4), and healthy

individuals (lanes 5 and 6). Specific accumulation of non-muscle alpha-Actinins (ACTN1
and ACTN4) was observed in samples of patients with mutations in KBTBD13. Muscle
alpha-Actinins (ACTN2 and 3) did not show abnormal accumulation. Porin and Ponceau
stain are shown as loading controls. (C) Immunofluorescence staining of cross-sections
from muscle biopsies of a healthy individual and a patient with a mutation in KBTBD13,
revealing a positive staining of nemaline bodies with non-muscle Alpha-actinins (ACTN1
and 4). Scale bars = 100µm (for A and C).

Figure 11. Model for the role of Cullin-3 during muscle fiber development.
S. Adaptor: substrate adaptor, Rbx1: RING-box protein 1, AchR: Acetylcholine Receptor,
Ub: Ubiquitin, N8: Nedd8

